Relationship Between Serum N/OFQ and Acute Myeloid Cell Leukemia
NCT06469047 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2024-06-21
Summary
Patients diagnosed with acute myeloid leukemia in the Second Hospital of Shanxi Medical University were selected and divided into the newly diagnosed group, the relapsed group, the complete remission group as the experimental group, and the healthy physical examination subjects as the control group. The relationship between IL-1β, catecholamine and norkephalin in peripheral blood of the experimental group and the control group was observed. According to the literature, the experimental group was significantly higher than the control group. In the experimental group, the newly diagnosed group was higher than the relapse group, and the relapse group was higher than the complete remission group, and the correlation was positive, and the difference was statistically significant.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Enzyme-linked immunosorbent assay
Serum N/OFQ , IL-1β and NE levels were detected.
Sponsors & Collaborators
-
Second Hospital of Shanxi Medical University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-20
- Primary Completion
- 2024-11-30
- Completion
- 2024-12-31
Countries
- China
Study Locations
More Related Trials
-
IL-6: A Marker for AML Chemo Sensitivity
NCT06486350 ·Status: RECRUITING
-
Single Cell Acute Leukemia Analysis
NCT06906978 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
NCT00899171 ·Status: COMPLETED
-
A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies
NCT06820268 ·Status: RECRUITING ·Phase: PHASE1
-
Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia
NCT01232842 ·Status: COMPLETED
-
NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy
NCT06024031 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL
NCT03123887 ·Status: COMPLETED
-
A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT05924750 ·Status: RECRUITING ·Phase: PHASE1
-
Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia
NCT01298414 ·Status: COMPLETED
-
NK Cell Therapy for AML
NCT05256277 ·Status: TERMINATED ·Phase: PHASE1
-
Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
NCT06651866 ·Status: RECRUITING ·Phase: PHASE1
-
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
NCT01421875 ·Status: COMPLETED
-
Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms
NCT01650467 ·Status: WITHDRAWN
-
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT06001788 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib
NCT04681820 ·Status: UNKNOWN
-
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
NCT01035307 ·Status: COMPLETED
-
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
NCT04087967 ·Status: UNKNOWN ·Phase: PHASE3
-
Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia
NCT07146542 ·Status: NOT_YET_RECRUITING
-
Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia
NCT06814444 ·Status: RECRUITING
-
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia
NCT00899743 ·Status: COMPLETED
-
A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
NCT05367765 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
NCT01057290 ·Status: COMPLETED
-
Incidence and Risk Factors for the Development of Invasive Fungal Infection in Patients Diagnosed With Acute Myeloblastic Leukemia (HIFA)
NCT07060612 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
NCT01004640 ·Status: UNKNOWN
-
Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)
NCT00129740 ·Status: COMPLETED ·Phase: PHASE2